http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201301170-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-34
filingDate 2012-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201301170-A1
titleOfInvention IMPROVED METHOD FOR OBTAINING RILPIVIRIN
abstract The present invention relates to the preparation of a key intermediate for rilpivirin, namely (E) -4- (2-cyanoethenyl) -2,6-dimethylphenylamine (II) hydrochloride, by a process involving the interaction of the tetrafluoroborate salt of a diazonium ion 2,6-dimethyl-4- amino-1-carboxybenzylphenylamine (VI) with acrylonitrile in the presence of palladium acetate, followed by acid conversion and its subsequent conversion to the hydrochloride (II) salt, while the undesired Z isomer has less than 0.5%, which gives rilpivirine hydrochloride having less than 0, 1% isomer Z.
priorityDate 2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410601636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431534772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9964218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11711114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90418829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454250970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450464172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167845

Total number of triples: 32.